RESEARCH-USE BIOSIMILAR ANTIBODY
Crexavibart
Monoclonal antibody · IgG1
Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain.
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-650
CATALOG NUMBERSC-BS-650
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain.
Crexavibart is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.